Cite

HARVARD Citation

    Ciccullo, A. et al. (2021). Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding. Journal of acquired immune deficiency syndromes. pp. 234-237. [Online]. 
  
Back to record